ALTO-207 in Adults With Treatment-resistant Depression (TRD)
Study sponsor: Alto Neuroscience
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2027-11Estimated
Enrollment · participants178Estimated
Source updated2026-10-26Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.